C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 31/7088 (2006.01) A61K 39/00 (2006.01) A61K 39/12 (2006.01) A61K 39/42 (2006.01) A61P 31/14 (2006.01) C07H 21/04 (2006.01) C12N 7/00 (2006.01) C12N 7/04 (2006.01) C12N 15/09 (2006.01)
Patent
CA 2483653
The invention relates to a dengue virus tetravalent vaccine containing a common 30 nucleotide deletion (.DELTA.30) in the 3'-untranslated region of the genome of dengue virus serotypes 1, 2, 3, and 4, or antigenic chimeric dengue viruses of serotypes 1, 2, 3, and 4.
La présente invention concerne un vaccin tétravalent contre le virus de la dengue comportant une suppression commune de 30 nucléotides (?30) dans la région 3' non traduite du génome du virus de la dengue des sérotypes 1, 2, 3 et 4 ou de virus antigène chimérique de la dengue des sérotyes 1, 2, 3 et 4.
Blaney Joseph
Falgout Barry
Hanley Kathryn
Markoff Lewis
Murphy Brian R.
Smart & Biggar
The Government Of The United States Of America
LandOfFree
Dengue tetravalent vaccine containing a common 30 nucleotide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dengue tetravalent vaccine containing a common 30 nucleotide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dengue tetravalent vaccine containing a common 30 nucleotide... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1785090